October 16, 2024 New TestOne order. One specimen. Rapid, informed decisions. NeoGenomics is proud to announce a new NGS-only assay for the assessment of acute myeloid leukemia (AML). NEO | AML Express provides class-leading turnaround time of 3-4 days, delivers a single report that offers a comprehensive NGS-based assessment, and aids in diagnosis, prognosis and therapy selection.
NEO | AML Express is a DNA & RNA next-generation sequencing (NGS) assay that is aligned with the latest guidelines, including the WHO 5th Edition Classification, for AML. - 38 genes by DNA sequencing for SNVs/InDels
- 9 genes by RNA sequencing for fusions
Test details: - Specimen Requirements: bone marrow (1-2 mL) or peripheral blood (2-3 mL) in EDTA
- Turnaround Time (TAT): 3-5 days
- Billing: Client-Bill only
- NYS Approval: No
IMPORTANT! To ensure fast TAT and specimen stability, please ship all orders directly to Neo Houston lab.
For more info, please contact your local NeoGenomics Territory Business Manager or visit the test menu page here. Test UpdatesMolecularNRAS Mutation Analysis
Effective Monday, October 28th, NRAS Mutation Analysis will be performed by real-time PCR instead of bi-directional Sanger sequencing. Shifting from Sanger to PCR will increase test sensitivity and create operational workflow efficiencies, allowing for continued focus on improving patient care. The following changes will be implemented for this test:
| New Test | NRAS Mutation Analysis by PCR | | Old (Discontinued) Test | NRAS Mutation Analysis
|
- Test Name Change to: NRAS Mutation Analysis by PCR
- Test Information: This test is a real-time PCR-based assay designed to detect somatic mutations in exons 2, 3 and 4 of the NRAS gene. Please note that the scoring of this test will indicate whether any pathogenic NRAS mutation was present, “Detected” or “Not Detected”, but the specific NRAS mutation will not be reported.
- CPT Code: 81311 (this test will no longer utilize 81403 in addition to 81311)
- No changes: to Specimen Requirements, CPT codes or TAT (7 days)
- Ordering: Online Orders will be updated with the new test name on the effective date. There is no change to the ordering name on test requisitions
- New York State Clients: This test is actively undergoing submission for NYS approval. NYS Clients will continue to be able to order the Sanger-based test until the new PCR test is approved. Stay tuned to NeoNEWS for continued updates on availability
- Interfaced clients: Please refer to the interface section of NeoNEWS for additional details
*The CPT codes provided with our test descriptions are based on AMA guidelines and are for informational purposes only. Correct CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. FISHEffective Monday, October 21st (postponed from October 14th), the FISH Signal Guide will be updated with the following changes. The updated FISH Signal Guide will be available for download on NeoLINK under Documentation on October 21. Test Discontinuations Effective Monday, November 4th, the tests listed below will be discontinued from our menu in an effort to streamline our offerings so that you have access to the most up-to-date solutions available while still maintaining our exceptional quality and service. Alternative test options, where available, have been listed for your reference. Please visit our website for our complete directory of tests.
We thank you for your continued trust in our service to support your patient care.
|